DLBCL ARISING FROM FOLLICULAR LYMPHOMA

Clinical trials for DLBCL ARISING FROM FOLLICULAR LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new DLBCL ARISING FROM FOLLICULAR LYMPHOMA trials appear

Sign up with your email to follow new studies for DLBCL ARISING FROM FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Scientists test 'Ready-Made' cell therapy for Tough-to-Treat blood cancers

Disease control Recruiting now

This is an early-stage safety study testing a new type of cell therapy called P-CD19CD20-ALLO1 for adults with aggressive B-cell lymphomas that have come back or not responded to standard treatments. The therapy uses genetically modified immune cells from a donor (not the patient…

Matched conditions: DLBCL ARISING FROM FOLLICULAR LYMPHOMA

Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

DLBCL ARISING FROM FOLLICULAR LYMPHOMA

Get alerted when new DLBCL ARISING FROM FOLLICULAR LYMPHOMA trials appear

Scientists test 'Ready-Made' cell therapy for Tough-to-Treat blood cancers